Company Announcement Presentations to Gastro 2007 Conference in St Petersburg The Directors of Solagran Limited are pleased to advise that three presentations in relation to Bioeffectives® will be delivered over the next two days at the Gastro 2007 conference in St Petersburg. Two will be delivered this evening Australian Eastern Standard Time. One will be delivered on 18 May. The presentations to be delivered on 17 May are: Randomized Double-blind Study of Efficacy and Safety of Ropren in the Treatment of Diseases of the Hepatobiliary System Soultanov V. S., Solagran Limited, Melbourne, Australia Roschin V. I., S. M. Kirov Forest Technical Academy, St Petersburg, Russia Lapteva E. N., St Petersburg Medical Academy of Postgraduate Studies, Russia Comparative Analysis of Antioxidant Activity of Bioeffective® A, in vitro and in vivo, for Acute Liver Damage Induced by Carbon Tetrachloride in Animals Soultanov V. S., Solagran Limited, Melbourne, Australia Roschin V. I., S. M. Kirov Forest Technical Academy, St Petersburg, Russia Nikitina T. V., Solagran Limited, St Petersburg, Russia Litinsky G., Solagran Limited, Melbourne, Australia The presentation to be delivered on 18 May is: Specific Activity of Polyprenol Preparation Ropren (Bioeffective® R) in Treating Toxic Liver Damage in Experimental Models Lapteva E. N., St Petersburg Medical Academy of Postgraduate Education, Russia Soultanov V. S., Solagran Limited, Melbourne, Australia Roschin V. I., S. M. Kirov Forest Technical Academy, St Petersburg, Russia Khnychenko L. K., Strategic Research Institute of Experimental Medicine, Russian Academy of Medical Science A summary of the key elements of Dr Soultanov’s presentation detailing the full results of the Ropren clinical trials will be released after the market closes today.
SLA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
